Perkins Capital Management’s Pulmonx LUNG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$51.4K Sell
39,500
-1,500
-4% -$2.07K 0.04% 77
2026
Q1
$52.9K Sell
41,000
-8,000
-16% -$13.2K 0.05% 83
2025
Q4
$108K Buy
49,000
+28,000
+133% +$52.6K 0.09% 84
2025
Q3
$34K Buy
21,000
+11,000
+110% +$23K 0.03% 83
2025
Q2
$25.9K Buy
+10,000
New +$39.4K 0.03% 82

Other funds holding LUNG

Perkins Capital Management's LUNG Position: Q2 2026 in Review

Perkins Capital Management reduced its Pulmonx (LUNG) stake by 3.7% in Q2 2026, selling an estimated $2.07K and leaving 39,500 shares worth $51.4K. The position accounts for 0.04% of the portfolio, ranked #77.

Perkins Capital Management first reported a position in LUNG in Q2 2025 and has held it in 5 quarters since. The position peaked at $108K in Q4 2025. 108 funds tracked by Wall St. Rank hold LUNG as of Q2 2026.

  • Perkins Capital Management held 39,500 shares of Pulmonx worth $51.4K as of Q2 2026.
  • Perkins Capital Management sold 1,500 Pulmonx shares in Q2 2026, an estimated $2.07K.
  • Pulmonx made up 0.04% of Perkins Capital Management's portfolio in Q2 2026, its #77 holding.
  • Perkins Capital Management first reported a position in Pulmonx in Q2 2025 and has held it in 5 quarters since.
  • Perkins Capital Management's Pulmonx position peaked at $108K in Q4 2025.
  • 108 funds tracked by Wall St. Rank held Pulmonx as of Q2 2026.

Based on Perkins Capital Management's 13F filing for Q2 2026, filed 24 Jul 2026.